Sequential re-rating: management describes the same offering landing bigger the second and third time around
The model's full reasoning — Q1 2024 call → NOWe need to determine if management describes successive engagements of the same kind coming in at progressively larger size. The question asks about deals, orders, contracts, projects, customers, sites, or programs. We need to see if management conveys that the unit size of its repeatable business is escalating. Looking at the transcript, there are mentions of TC/RC negotiations, copper prepayment facility, etc. But the key is whether management says that the deals they are landing now are individually bigger, broader, or longer than before. In the transcript, David Strang mentions: "we've been taking advantage of what a lot of people know in the marketplace is the favorable TC/RC terms. We've entered into two contracts so far. They will be kicking in from May onwards this month onwards two-year contracts for about one-third of our production." That's about locking in terms, not about size escalation. There is also mention of the copper prepayment facility: "We have also entered into a $50 million non-priced copper prepayment facility subsequent to the quarter end." That's a single facility, not necessarily a pattern. The question is about successive engagements of the same kind coming in at progressively larger size. For example, if they sign contracts for offtake, are those contracts getting bigger? They mention two contracts for one-third of production, but that's not necessarily larger than previous ones. They don't compare to past deals. Also, they talk about the Tucuma project, but that's a project, not a repeatable business. The question specifically asks: "does management convey that the deals, orders, contracts, projects, customers, sites, or programs it is landing NOW are individually bigger, broader, or longer than the ones it was landing for the same offering not long ago?" There is no such comparison in the transcript. Management talks about strong performance, but not about escalation of unit size. They mention "we are on track to reach our highest annual production levels ever" but that's volume, not unit size. They also mention "we are raising our 2024 gold production guidance" but that's volume. There is no mention of larger contracts, larger orders, larger projects, etc. The only thing that might be relevant is the TC/RC contracts, but they don't say they are larger than previous ones. Thus, the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| ASO | Academy Sports and Outdoors, Inc. | Q1 2024 | 2024-06-11 | C+ |
| AKYA | Akoya Biosciences, Inc. | Q2 2023 | 2023-08-07 | C+ |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
AKYA · Q2 2023 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing a clear pattern of escalating project sizes in the translational/clinical space. Brian notes a migration from exploratory studies (reasonable size) to larger retrospective studies and even larger retrospective-prospective ongoing clinical studies, with projects moving "further and further downstream.
ASAN · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES Management describes exactly this pattern. Dustin notes the company is “closing larger deals and expanding seats across departments and geographies quickly in large organizations,” and that the growth in the >$50k cohort “reflected an acceleration in our largest enterprise customers.
SGRY · Q2 2022 → YESThe question is: Does management describe that the company's SUCCESSIVE ENGAGEMENTS OF THE SAME KIND ARE COMING IN AT PROGRESSIVELY LARGER SIZE? YES The transcript shows management describing exactly this pattern for physician recruiting cohorts. Wayne notes that the 2022 cohorts are “no exception to this trend, bringing more cases with a higher overall net revenue per case than our 2021 cohorts did in the same period last year.